# Strategy of Early Improvement of Tissue Oxygenation Decrease the Mortality of Severe Sepsis and Septic Shock

> **NCT01310790** · PHASE4 · COMPLETED · sponsor: **Chinese Septic Shock Network** · enrollment: 420 (actual)

## Conditions studied

- Shock, Septic

## Interventions

- **PROCEDURE:** lactate group:lactate acide clearance directed group; ScvO2 group:ScvO2 directed group;control group

## Key facts

- **NCT ID:** NCT01310790
- **Lead sponsor:** Chinese Septic Shock Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 420 (ACTUAL)
- **Last updated:** 2011-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01310790

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01310790, "Strategy of Early Improvement of Tissue Oxygenation Decrease the Mortality of Severe Sepsis and Septic Shock". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01310790. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*